198 related articles for article (PubMed ID: 25097557)
1. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes.
Tormo A; Celada F; Rodriguez S; Botella R; Ballesta A; Kasper M; Ouhib Z; Santos M; Perez-Calatayud J
J Contemp Brachytherapy; 2014 Jun; 6(2):167-72. PubMed ID: 25097557
[TBL] [Abstract][Full Text] [Related]
2. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series.
Delishaj D; Laliscia C; Manfredi B; Ursino S; Pasqualetti F; Lombardo E; Perrone F; Morganti R; Paiar F; Fabrini MG
J Contemp Brachytherapy; 2015 Dec; 7(6):437-44. PubMed ID: 26816500
[TBL] [Abstract][Full Text] [Related]
3. Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy.
Laliscia C; Coccia N; Fuentes T; Perrone F; Paiar F
J Contemp Brachytherapy; 2021 Dec; 13(6):615-619. PubMed ID: 35079246
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma.
Ruiz MÁG; Rivero JQ; García JLM; Rodríguez JJC; Kavadoy YR; Carmona MFR; Campos AC; Urra FG; Muñoz MCC; Herrero AR; Manzano PA
J Contemp Brachytherapy; 2017 Dec; 9(6):561-565. PubMed ID: 29441101
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
6. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
7. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
8. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
9. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer.
Bhatnagar A; Loper A
Radiat Oncol; 2010 Sep; 5():87. PubMed ID: 20875139
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer.
Pellizzon ACA; Fogaroli R; Chen MJ; Maia P; Gondim G; Guedes DC; Ramos H; Silva MLG
J Contemp Brachytherapy; 2020 Oct; 12(5):435-440. PubMed ID: 33299432
[TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
12. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
[TBL] [Abstract][Full Text] [Related]
13. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique.
Brovchuk S; Park SJ; Shepil Z; Romanenko S; Vaskevych O
J Contemp Brachytherapy; 2022 Apr; 14(2):107-114. PubMed ID: 35494184
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric characteristics of a new unit for electronic skin brachytherapy.
Garcia-Martinez T; Chan JP; Perez-Calatayud J; Ballester F
J Contemp Brachytherapy; 2014 Mar; 6(1):45-53. PubMed ID: 24790622
[TBL] [Abstract][Full Text] [Related]
16. Correction factors for ionization chamber measurements with the 'Valencia' and 'large field Valencia' brachytherapy applicators.
Gimenez-Alventosa V; Gimenez V; Ballester F; Vijande J; Andreo P
Phys Med Biol; 2018 Jun; 63(12):125004. PubMed ID: 29726409
[TBL] [Abstract][Full Text] [Related]
17. Optimizing surface mould brachytherapy for treatment of nasal basal cell carcinoma using customized applicators.
Barnes EA; Tsao MN; Taggar AS; Ravi A; Paudel MR
Brachytherapy; 2023; 22(5):665-672. PubMed ID: 37277286
[TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.
Delishaj D; Rembielak A; Manfredi B; Ursino S; Pasqualetti F; Laliscia C; Orlandi F; Morganti R; Fabrini MG; Paiar F
J Contemp Brachytherapy; 2016 Dec; 8(6):533-540. PubMed ID: 28115960
[TBL] [Abstract][Full Text] [Related]
19. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
20. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
Bhatnagar A
Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
